N-SUBSTITUTED SPIROPIPERIDINE COMPOUNDS AS LIGANDS FOR ORL-1 RECEPTOR

Details for Australian Patent Application No. 2003201712 (hide)

Owner PFIZER PHARMACEUTICALS INC.

Inventors ITO, Fumitaka; KOIKE, Hiroki; MORITA, Asato

Pub. Number AU-A-2003201712

PCT Number PCT/IB03/00203

PCT Pub. Number WO2003/064425

Priority 60/352,437 28.01.02 US

Filing date 16 January 2003

Wipo publication date 2 September 2003

International Classifications

C07D 487/06 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/06 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/10 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/4738 - ortho- or peri-condensed with heterocyclic ring systems

A61K 031/5383

A61P 025/04 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/352,437 28.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003201712

14 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003201713-CONTROLLED RELEASE PHARMACEUTICAL DOSAGE FORMS OF A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR

2003201711-PROCESS OF PREPARING A PHARMACEUTICAL COMPOSITION FOR IMMUNITY AGAINST TUBERCULOSIS IN HIV POSITIVE INDIVIDUALS